Kiora Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€0.69
Target price
31.12.25
€1.00
Performance (%)
-37.75%
End price
14.12.24
-
Summary
This prediction is currently being closed. Massive losses of -37.75% have been the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Kiora Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
According to BiotechBee what are the pros and cons of Kiora Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year